Effects of iron deprivation or chelation on DNA damage in experimental colitis

International Journal of Colorectal Disease

Volumn 19, Issue 5, 2004, Pages 461-466

  Barollo, M ^a   D'Inca R ^a   Scarpa, M ^a   Medici, V ^a   Cardin, R ^a   Fries, W ^b   Agriman, I ^a   Sturniolo, G C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Desferrioxamine; DNA damage; Experimental colitis; Iron

Indexed keywords

DEFEROXAMINE; DNA; HYDROXYL RADICAL; IRON; NITROBENZENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER PREVENTION; COLITIS; COLON INJURY; CONTROLLED STUDY; DIARRHEA; DIETARY INTAKE; DISEASE SEVERITY; DNA ADDUCT; DNA DAMAGE; DRUG USE; ENTERITIS; GENETIC DAMAGE; IRON CHELATION; LIVER LEVEL; MALE; NONHUMAN; OCCULT BLOOD; PRIORITY JOURNAL; RAT; SCORING SYSTEM; WEIGHT REDUCTION;

EID: 4444296174     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-004-0588-2     Document Type: Article

References (37)

1. Babbs CF (1992) Oxygen radicals in ulcerative colitis. Free Rad Biol Med 13:169-182
2. Lih-Brodi L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, et al (1996) Increased oxidative stress and decreased antioxidant defences in mucosa of inflammatory bowel disease. Dig Dis Sci 41:2078-2086
3. Sturniolo GC, Mestriner C, Lecis PE, D'Odorico A, Venturi C, Irato P, Cecchetto A, Tropea A, Longo G, et al (1998) Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol 33:644-649
4. Halliwell B, Gutteridge JMC (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 86:1-85
5. Eybl V, Kotyzova D, Kolek M, Katensky J, Nielsen P (2002) The influence of Deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice. Toxicol Lett 128:169-175
6. Winyard PG, Blake DR, Chirico S, Gutteridge JM, Lunec J (1987) Mechanism of exacerbation of rheumatoid synovitis by tota-dose iron infusion: invivo demonstration of iron-promoted oxidant stress. Lancet 1:69-72
7. Kawai M, Sumimoto S, Kasajima Y, Hamamoto T (1992) A case of ulcerative colitis induced by oral ferrous sulfate. Acta Paediatr Jpn 34:476-478
8. Erichsen K, Hausken T, Berge R (1998) Effect of oral iron therapy on antioxidant defense in active Crohn's disease. Digestion 59:FOLM 1287
9. Cuzzocrea S, Mazzon E, De Sarro A, Caputi AP (2000) Role of free radicals and poly (ADP-ribose) synthethase in intestinal tight junction permeability. Mol Med 6:766-778
10. Robinson CE, Kottapalli V, D'Astice M, Fields JZ, Winship D, Keshavarzian A (1997) Regulation of neutrophils in ulcerative colitis by colonic factors: a possible mechanism of neutrophil activation and tissue damage. J Lab Clin Med 130:590-606
11. Lin M, Rippe RA, Niemela O, Brittenham G, Tsukamoto H (1997) Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol 272:G1355-64
12. Schmidt KN, Amstad P, Cerutti B, Baeuerle PA (1995) The role of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kB. Chem Biol 2:13-22
13. Halliwell B, Aruoma OL (1991) DNA damage by oxygen-derived species. FEBS Lett 281:9-19
14. Toyokuni S (2002) Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rep 7:189-197
15. Polla BS (1999) Therapy by taking away: the case of iron. Biochem Pharmacol 57:1345-1349
16. Giardina PJ, Grady RW. (1995) Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine. Semin Hematol 32:304-312
17. Donfrancesco A, De Bernardi B, Carli M, Mancini A, Nigro M, De Sio L, Casale F, Bagnulo S, Helson L, et al (1995) Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group. Eur J Cancer 31A:612-615
18. Crapper MDR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W (1991) Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337:1304-1308
19. Kruck TP, Fischer EA, Mc Lachlan DR (1993) A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate. Clin Pharmacol Ther 53:30-37
20. Schnellmann JG, Pumford NR, Kusewitt DF, Bucci TJ, Hinson JA (1999) Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice. Toxicol Lett 106:79-88
21. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 98:795-803
22. Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN (1990) Oxidative damage to DNA during aging: 8-hy-droxy-2-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 87:4533-4537
23. Helbock HJ, Beckman KB, Shigenaga MK, Walter PB, Woodall AA, Yeo HC, Ames BN (1998) DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanosine. Proc Natl Acad Sci USA 95:288-293
24. Reifen R, Matas Z, Zeidel L, Berkovitch Z, Bujanover Y (2000) Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci 45:394-397
25. Carrier J, Aghdassi E, Platt I, Mullen J, Allard JP (2001) Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 15:1989-1999
26. Carrier J, Aghdassi E, Cullen J, Allord JP (2002) Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr 132:3146-3150
27. Haq RU, Werely JP, Chitambar CR (1995) Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells. Exp Hematol 23:428-432
28. Kovar J, Stunz LL, Stewart BC, Kriegerbeckova K, Ashman RF, Kemp JD (1997) Direct evidence that iron deprivation induces apoptosis in murine lymphoma. 38C13. Pathobiology 65:61-68
29. Toyokuni S (2002) Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rep 7:189-197
30. Ablin J, Shalev O, Okon E, Karmeli F, Rachmilewitz D (1999) Deferiprone, an oral iron chelator, ameliorates experiment colitis and gastric ulceration in rats. Inflamm. Bowel Dis 5:253-261
31. Emerit J, Pelletier S, Likforman J, Pasquier C, Thuillier A (1991) Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radic Res Commun 12-13:563-569
32. Millar AD, Rampton DS, Blake DR (2000) Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther 14:1163-1168
33. Carotenuto P, Pontesilli O, Cambier JC, Hayward AR (1986) Desferoxamine blocks IL 2 receptor expression on human T lymphocytes. J Immunol 136:2342-2347
34. Hoffbrand AV, Ganeshaguru K, Hooton JW, Tattersal MH (1976) Effects of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol 33:517-526
35. Oldemburg B, Koningsberger JC, Van Berge Henegouwen GP, Van Asbeck BS, Marks JJM (2001) Review article: iron and inflammatory bowel disease. Aliment Pharmacol Ther 15:429-438
36. Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY (2002) Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 47:1266-278
37. Christensen DW, Kisling R, Thompson J, Kirby MA (2001) Deferoxamine toxicity in hepatoma and primary rat cortical brain cultures. Hum Exp Toxicol 20:365-372